Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 13
1967 15
1968 12
1969 2
1970 13
1971 3
1972 5
1973 2
1974 7
1975 11
1976 26
1977 49
1978 94
1979 120
1980 3669
1981 7562
1982 7343
1983 7412
1984 7584
1985 7515
1986 7588
1987 7803
1988 7698
1989 8011
1990 8094
1991 8267
1992 8189
1993 8195
1994 8570
1995 8452
1996 8338
1997 8290
1998 8538
1999 8971
2000 9362
2001 10053
2002 10472
2003 11220
2004 12058
2005 13259
2006 14313
2007 15670
2008 18052
2009 19476
2010 21814
2011 23637
2012 25342
2013 27311
2014 27862
2015 28181
2016 27950
2017 25910
2018 25722
2019 25745
2020 27727
2021 28199
2022 25576
2023 24950
2024 15658
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

614,205 results

Results by year

Filters applied: . Clear all
Page 1
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population.
Wang AZ, Mashimo BL, Schaettler MO, Sherpa ND, Leavitt LA, Livingstone AJ, Khan SM, Li M, Anzaldua-Campos MI, Bradley JD, Leuthardt EC, Kim AH, Dowling JL, Chicoine MR, Jones PS, Choi BD, Cahill DP, Carter BS, Petti AA, Johanns TM, Dunn GP. Wang AZ, et al. Cancer Discov. 2024 Jun 3;14(6):1106-1131. doi: 10.1158/2159-8290.CD-23-0913. Cancer Discov. 2024. PMID: 38416133
NCI Cancer Research Data Commons: Lessons Learned and Future State.
Kim E, Davidsen T, Davis-Dusenbery BN, Baumann A, Maggio A, Chen Z, Meerzaman D, Casas-Silva E, Pot D, Pihl T, Otridge J, Shalley E; CRDC Program; Barnholtz-Sloan JS, Kerlavage AR. Kim E, et al. Cancer Res. 2024 May 2;84(9):1404-1409. doi: 10.1158/0008-5472.CAN-23-2730. Cancer Res. 2024. PMID: 38488510 Free PMC article. Review.
Knowledge is power.
DiGiovanna JJ, Kraemer KH. DiGiovanna JJ, et al. Br J Dermatol. 2022 Apr;186(4):607-608. doi: 10.1111/bjd.21008. Epub 2022 Mar 30. Br J Dermatol. 2022. PMID: 35355250 No abstract available.
Update in the management of gastroenteropancreatic neuroendocrine tumors.
Sedlack AJH, Varghese DG, Naimian A, Yazdian Anari P, Bodei L, Hallet J, Riechelmann RP, Halfdanarson T, Capdevilla J, Del Rivero J. Sedlack AJH, et al. Cancer. 2024 Sep 15;130(18):3090-3105. doi: 10.1002/cncr.35463. Epub 2024 Jul 16. Cancer. 2024. PMID: 39012928 Review.
Green Cancer Prevention and Beyond.
Ross SA, Emenaker NJ, Kumar A, Riscuta G, Biswas K, Gupta S, Mohammed A, Shoemaker RH. Ross SA, et al. Cancer Prev Res (Phila). 2024 Mar 4;17(3):107-118. doi: 10.1158/1940-6207.CAPR-23-0308. Cancer Prev Res (Phila). 2024. PMID: 38251904 Free PMC article. Review.
Genomic testing and patient rights.
Jones CM, Karp J, Davis DS. Jones CM, et al. J Natl Cancer Inst. 2024 May 8;116(5):771-772. doi: 10.1093/jnci/djae043. J Natl Cancer Inst. 2024. PMID: 38412308 No abstract available.
614,205 results
You have reached the last available page of results. Please see the User Guide for more information.